DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Molecular Imaging Homepage

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Researchers develop targeted alpha therapy protocol for prostate cancer Determines most effective therapy with the least number of side effects

Eyeing theranostics, Sofie Biosciences completes acquisition of Zevacor Pharma Growth of FDG also influenced decision

Blue Earth Diagnostics partners with GE to manufacture Axumin PET agent in UK Agreements were made in other European countries

RefleXion Medical selects MedCrypt to secure its new radiotherapy technology Updated FDA guidelines put cybersecurity at forefront

PET imaging used for the first time to evaluate Zika virus in mouse model May aid in development of therapeutic agents

Philips introduces its CardioMD IV SPECT system at ASNC meeting Smaller footprint and lower cost of ownership

PET/MR scans can assess pediatric cancer survivor health Study targets chemotherapy after-effects in young patients

New publication calls for greater research and investment in theranostics Imaging a future with dedicated theranostics treatment centers

Imaging technology scans reveal trend in kidney cancer rates may be at an end Used CT, MRI, PET and ultrasound scans

UAlberta researchers in the lab

Two new imaging agents may help physicians make better and quicker treatment decisions

by Lauren Dubinsky , Senior Reporter
Two new imaging agents may help physicians personalize cancer therapy and determine a patient's response to a drug 24 hours after it's administered.

These imaging agents can be used with PET and fluorescence imaging to visualize the formation of tumor-associated blood vessels and track tumor growth.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory DOTmed Certified



Researchers at the University of Alberta in Canada worked with colleagues at Western University and Case Western Reserve University to develop the imaging agents. They investigated a protein called EGFL7 that is specific to actively growing blood vessels.

The team started by creating peptides that attach to EGFL7 proteins in order to determine if they would be useful for imaging applications. PET exams using the peptide were performed on mice with tumors in order to localize the tumors and illuminate them.

They also used the peptide to create nanoparticles and those were shown to accumulate in the new blood vessels and illuminate as well.

Many cancer drugs on the market inhibit the formation of new tumor-related blood vessels, but it's difficult to determine which patients would benefit from them. They can be toxic for one patient and lifesaving for another.

The team believes that these new imaging agents can provide physicians with the information they need to make more personalized treatment decisions.

The agent can be used prior to treatment in order to see how many blood vessels are forming. That would determine whether an individual patient is a candidate for those drugs.

The agents can also be used during treatment to monitor their response to therapy. Traditionally, physicians measure changes in tumor size up to a month after treatment, but this new method could determine that in 24 hours.

The next step is to test the imaging agents in a treatment setting. The researchers will initially perform experiments on animal models and then move on to clinical work.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED